Oral vaccine delivery: can it protect against non-mucosal pathogens? (Q37229915)

19 August 2017

1 reference

title

Oral vaccine delivery: can it protect against non-mucosal pathogens? (English)

1 reference

19 August 2017

0 references

2

Ross L Coppel

1 reference

19 August 2017

Lina Wang

1

1 reference

19 August 2017

publication date

1 August 2008

1 reference

Expert Review of Vaccines

19 August 2017

published in

1 reference

19 August 2017

volume

7

1 reference

19 August 2017

issue

6

1 reference

19 August 2017

page(s)

729-738

1 reference

Oral vaccination: where we are?

19 August 2017

cites work

1 reference

https://api.crossref.org/works/10.1586%2F14760584.7.6.729

Delivery systems and adjuvants for oral vaccines.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.7.6.729

Orally delivered malaria vaccines: not too hard to swallow

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.7.6.729

Acquired immunodeficiency syndrome in Romania

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.7.6.729

Use of live bacterial vaccine vectors for antigen delivery: potential and limitations

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.7.6.729

Salmonella: immune responses and vaccines

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.7.6.729

Live-attenuated Salmonella as a prototype vaccine vector for passenger immunogens in humans: are we there yet?

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.7.6.729

Rational design of Salmonella recombinant vaccines

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.7.6.729

Implication of nanoparticles/microparticles in mucosal vaccine delivery

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.7.6.729

Antigen delivery to mucosa-associated lymphoid tissues using liposomes as a carrier

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.7.6.729

HBV core particles as a carrier for B cell/T cell epitopes

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.7.6.729

Oral immunization of adult volunteers with microencapsulated enterotoxigenic Escherichia coli (ETEC) CS6 antigen

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.7.6.729

Genetically manipulated bacterial toxin as a new generation mucosal adjuvant

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.7.6.729

Recombinant virus-like particles of a norovirus (genogroup II strain) administered intranasally and orally with mucosal adjuvants LT and LT(R192G) in BALB/c mice induce specific humoral and cellular Th1/Th2-like immune responses

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.7.6.729

Safety evaluation of recombinant cholera toxin B subunit produced by Bacillus brevis as a mucosal adjuvant

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.7.6.729

Molecular farming for new drugs and vaccines. Current perspectives on the production of pharmaceuticals in transgenic plants

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.7.6.729

Transgenic plants in the biopharmaceutical market.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.7.6.729

Production of biopharmaceuticals and vaccines in plants via the chloroplast genome

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.7.6.729

Viral vectors for the expression of proteins in plants

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.7.6.729

Progress towards the development of malaria vaccines

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.7.6.729

Vaccines against malaria - an update

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.7.6.729

Mucosal immunisation of mice with malaria protein on lactic acid bacterial cell walls

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.7.6.729

Immunogenicity of a malaria parasite antigen displayed by Lactococcus lactis in oral immunisations

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.7.6.729

Safety of the RTS,S/AS02D candidate malaria vaccine in infants living in a highly endemic area of Mozambique: a double blind randomised controlled phase I/IIb trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.7.6.729

Oral Salmonella typhimurium vaccine expressing circumsporozoite protein protects against malaria

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.7.6.729

Oral Salmonella: malaria circumsporozoite recombinants induce specific CD8+ cytotoxic T cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.7.6.729

Generation of a cytotoxic T-lymphocyte response using a Salmonella antigen-delivery system

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.7.6.729

Salmonella typhi vaccine strain CVD 908 expressing the circumsporozoite protein of Plasmodium falciparum: strain construction and safety and immunogenicity in humans.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.7.6.729

Enhanced immunity to Plasmodium falciparum circumsporozoite protein (PfCSP) by using Salmonella enterica serovar Typhi expressing PfCSP and a PfCSP-encoding DNA vaccine in a heterologous prime-boost strategy

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.7.6.729

Expression, extracellular secretion, and immunogenicity of the Plasmodium falciparum sporozoite surface protein 2 in Salmonella vaccine strains.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.7.6.729

Expression of the Plasmodium falciparum immunodominant epitope (NANP)(4) on the surface of Salmonella enterica using the autotransporter MisL

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.7.6.729

Surface expression of malarial antigens in Salmonella typhimurium: induction of serum antibody response upon oral vaccination of mice

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.7.6.729

Expression of disulphide-bridge-dependent conformational epitopes and immunogenicity of the carboxy-terminal 19 kDa domain of Plasmodium yoelii merozoite surface protein-1 in live attenuated Salmonella vaccine strains

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.7.6.729

Construction and immunogenicity in mice of attenuated Salmonella typhi expressing Plasmodium falciparum merozoite surface protein 1 (MSP-1) fused to tetanus toxin fragment C.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.7.6.729

Expression of fragment C of tetanus toxin fused to a carboxyl-terminal fragment of diphtheria toxin in Salmonella typhi CVD 908 vaccine strain

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.7.6.729

Oral immunization with a recombinant malaria protein induces conformational antibodies and protects mice against lethal malaria

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.7.6.729

Oral immunization with a combination of Plasmodium yoelii merozoite surface proteins 1 and 4/5 enhances protection against lethal malaria challenge

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.7.6.729

Immunization with a combination of merozoite surface proteins 4/5 and 1 enhances protection against lethal challenge with Plasmodium yoelii.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.7.6.729

Immunogenicity of Plasmodium yoelii merozoite surface protein 4/5 produced in transgenic plants

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.7.6.729

Serum antibodies induced by intranasal immunization of mice with Plasmodium vivax Pvs25 co-administered with cholera toxin completely block parasite transmission to mosquitoes

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.7.6.729

Nasal immunization with a malaria transmission-blocking vaccine candidate, Pfs25, induces complete protective immunity in mice against field isolates of Plasmodium falciparum

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.7.6.729

Intranasal immunization with yeast-expressed 19 kD carboxyl-terminal fragment of Plasmodium yoelii merozoite surface protein-1 (yMSP119) induces protective immunity to blood stage malaria infection in mice

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.7.6.729

Adjuvant requirement for successful immunization with recombinant derivatives of Plasmodium vivax merozoite surface protein-1 delivered via the intranasal route

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.7.6.729

Immune response after oral administration of the encapsulated malaria synthetic peptide SPf66.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.7.6.729

Remarkably high antibody levels and protection against P. falciparum malaria in Aotus monkeys after a single immunisation of SPf66 encapsulated in PLGA microspheres

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.7.6.729

Potent, long lasting systemic antibody levels and mixed Th1/Th2 immune response after nasal immunization with malaria antigen loaded PLGA microparticles.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.7.6.729

The vaccine is dead--long live the vaccine

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.7.6.729

Oral immunisation of mice with live Japanese encephalitis virus induces a protective immune response

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.7.6.729

Oral immunization of mice with Japanese encephalitis virus envelope protein synthesized in Escherichia coli induces anti-viral antibodies

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.7.6.729

A DNA prime, orally delivered protein boost vaccination strategy against viral encephalitis

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.7.6.729

Oral hepatitis B vaccine candidates produced and delivered in plant material

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.7.6.729

Development of hepatitis B oral vaccine using B-cell epitope loaded PLG microparticles.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.7.6.729

Expression of hepatitis B surface antigen in transgenic plants

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.7.6.729

Oral immunization with hepatitis B surface antigen expressed in transgenic plants

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.7.6.729

Immunogenicity in humans of an edible vaccine for hepatitis B.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.7.6.729

Vaccination strategies for mucosal immune responses

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.7.6.729

The failed HIV Merck vaccine study: a step back or a launching point for future vaccine development?

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.7.6.729

The pentavalent rotavirus vaccine, RotaTeq

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.7.6.729

Immune responses to dietary antigens: oral tolerance.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.7.6.729

Recombinant liveSalmonellaspp. for human vaccination against heterologous pathogens

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.7.6.729

Production of hepatitis B surface antigen in transgenic plants for oral immunization

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.7.6.729

Crude saponins improve the immune response to an oral plant-made measles vaccine

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.7.6.729

21 January 2018

Identifiers

DOI

10.1586/14760584.7.6.729

1 reference

19 August 2017

1 reference